701 related articles for article (PubMed ID: 31471754)
1. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
Lee S; Kim KW; Jeong WK; Kim MJ; Choi GH; Choi JS; Song GW; Lee SG
Eur Radiol; 2020 Feb; 30(2):987-995. PubMed ID: 31471754
[TBL] [Abstract][Full Text] [Related]
2. Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma.
Kim AY; Sinn DH; Jeong WK; Kim YK; Kang TW; Ha SY; Park CK; Choi GS; Kim JM; Kwon CHD; Joh JW; Kim MJ; Sohn I; Jung SH; Paik SW; Lee WJ
J Hepatol; 2018 Jun; 68(6):1144-1152. PubMed ID: 29410377
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MR imaging can predict early recurrence after curative resection using image features and texture analysis.
Ahn SJ; Kim JH; Park SJ; Kim ST; Han JK
Abdom Radiol (NY); 2019 Feb; 44(2):539-548. PubMed ID: 30229421
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
[TBL] [Abstract][Full Text] [Related]
5. The value of the signal intensity of peritumoral tissue on Gd-EOB-DTPA dynamic enhanced MRI in assessment of microvascular invasion and pathological grade of hepatocellular carcinoma.
Wang LL; Li JF; Lei JQ; Guo SL; Li JK; Xu YS; Dou Y
Medicine (Baltimore); 2021 May; 100(20):e25804. PubMed ID: 34011043
[TBL] [Abstract][Full Text] [Related]
6. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma.
Lee S; Kim SH; Lee JE; Sinn DH; Park CK
J Hepatol; 2017 Sep; 67(3):526-534. PubMed ID: 28483680
[TBL] [Abstract][Full Text] [Related]
7. LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection.
Wei H; Jiang H; Zheng T; Zhang Z; Yang C; Ye Z; Duan T; Song B
Eur Radiol; 2021 Apr; 31(4):2289-2302. PubMed ID: 33001306
[TBL] [Abstract][Full Text] [Related]
8. Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation.
Huang K; Dong Z; Cai H; Huang M; Peng Z; Xu L; Jia Y; Song C; Li ZP; Feng ST
BMC Cancer; 2019 Apr; 19(1):364. PubMed ID: 30999947
[TBL] [Abstract][Full Text] [Related]
9. Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.
Cha DI; Kang TW; Jeong WK; Kim JM; Choi GS; Joh JW; Yi NJ; Ahn SH
Eur Radiol; 2024 Jan; 34(1):498-508. PubMed ID: 37505248
[TBL] [Abstract][Full Text] [Related]
10. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
[TBL] [Abstract][Full Text] [Related]
11. VICT2 Trait: Prognostic Alternative to Peritumoral Hepatobiliary Phase Hypointensity in HCC.
Jiang H; Wei H; Yang T; Qin Y; Wu Y; Chen W; Shi Y; Ronot M; Bashir MR; Song B
Radiology; 2023 Apr; 307(2):e221835. PubMed ID: 36786702
[TBL] [Abstract][Full Text] [Related]
12. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma.
Chou YC; Lao IH; Hsieh PL; Su YY; Mak CW; Sun DP; Sheu MJ; Kuo HT; Chen TJ; Ho CH; Kuo YT
World J Gastroenterol; 2019 Jun; 25(21):2636-2649. PubMed ID: 31210715
[TBL] [Abstract][Full Text] [Related]
13. Peritumoral decreased uptake area of gadoxetic acid enhanced magnetic resonance imaging and tumor recurrence after surgical resection in hepatocellular carcinoma: A STROBE-compliant article.
Shin SK; Kim YS; Shim YS; Choi SJ; Park SH; Jung DH; Kwon OS; Choi DJ; Kim JH
Medicine (Baltimore); 2017 Aug; 96(33):e7761. PubMed ID: 28816953
[TBL] [Abstract][Full Text] [Related]
14. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
[TBL] [Abstract][Full Text] [Related]
15. Prediction for Aggressiveness and Postoperative Recurrence of Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced Magnetic Resonance Imaging.
Lu M; Qu Q; Xu L; Zhang J; Liu M; Jiang J; Shen W; Zhang T; Zhang X
Acad Radiol; 2023 May; 30(5):841-852. PubMed ID: 36577606
[TBL] [Abstract][Full Text] [Related]
16. Liver Imaging Reporting and Data System Category on Magnetic Resonance Imaging Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation Within the Milan Criteria: A Multicenter Study.
Lee S; Kim KW; Jeong WK; Jeong SY; Hwang JA; Choi JS; Lee SG; Joh JW
Ann Surg Oncol; 2021 Oct; 28(11):6782-6789. PubMed ID: 33751296
[TBL] [Abstract][Full Text] [Related]
17. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.
Lee DH; Lee JM; Yu MH; Hur BY; Yi NJ; Lee KW; Suh KS; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
Eur Radiol; 2019 Jun; 29(6):3122-3131. PubMed ID: 30643939
[TBL] [Abstract][Full Text] [Related]
18. Prediction of HCC microvascular invasion with gadobenate-enhanced MRI: correlation with pathology.
Zhang L; Yu X; Wei W; Pan X; Lu L; Xia J; Zheng W; Jia N; Huo L
Eur Radiol; 2020 Oct; 30(10):5327-5336. PubMed ID: 32367417
[TBL] [Abstract][Full Text] [Related]
19. The role of gadoxetic acid-enhanced MRI features for predicting microvascular invasion in patients with hepatocellular carcinoma.
Yang H; Han P; Huang M; Yue X; Wu L; Li X; Fan W; Li Q; Ma G; Lei P
Abdom Radiol (NY); 2022 Mar; 47(3):948-956. PubMed ID: 34962593
[TBL] [Abstract][Full Text] [Related]
20. Hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with HCC: prognostic features before resection, ablation, or TACE.
Bae JS; Kim JH; Lee DH; Kim JH; Han JK
Eur Radiol; 2021 Jun; 31(6):3627-3637. PubMed ID: 33211146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
